⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 12, 2005CancerOpen Access

Strategies to diagnose lymphoproliferative disorders by fine-needle aspiration by using ancillary studies

Nancy P. Caraway

View Full Paper

Ask AI

Bookmark

Share

Abstract

This article outlines a multiparameter approach to diagnosing lymphoproliferative disorders by fine-needle aspiration.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Nancy P. Caraway (2005) studied this question.

synapsesocial.com/papers/6a7fbfdeb3cd23f09042226b https://doi.org/10.1002/cncr.21452

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Hodgkin’s Disease: Diagnosis by Fine-Needle Aspiration Biopsy: Analysis of Cytologic Criteria from a Selected SeriesRetrospective Study · 1986 · 53 citations
2The value of immunocytochemical staining of lymph node aspirates in diagnostic cytologyOriginal Research · 1988 · 50 citations
3Fine-Needle Aspiration Cytology of Peripheral T-Cell Lymphoma: A Cytologic, Immunologic, and Cytometric StudyOriginal Research · 1989 · 62 citations
4Fine needle aspiration diagnosis of intraabdominal and retroperitoneal lymphomas by a morphologic and immunocytochemical approachCohort Study · 1990 · 100 citations
5Fine-needle aspiration evaluation of lymphoproliferative lesions in human immunodeficiency virus-positive patients. A multiparameter approachOriginal Research · 1991 · 14 citations

More related papers

The Role of Gene Rearrangements for Antigen Receptors in the Diagnosis of Lymphoma Obtained by Fine-Needle Aspiration: A Study of 63 Cases with Concomitant Immunophenotyping1991
Immunotyping of Lymphoma by Fine-needle Aspiration:A Comparative Study of Cytospin Preparations and Flow Cytometry1994
Combining fine-needle aspiration and flow cytometric immunophenotyping in evaluation of nodal and extranodal sites for possible lymphoma: A retrospective review1997

More from Cancer

Cancer risks associated with BRCA1 and BRCA2 : Overview and managementWed,
Real‐world outcomes in circulating tumor DNA–detected isocitrate dehydrogenase 1–mutant cholangiocarcinoma: First‐line gemcitabine and cisplatin with versus without immunotherapyWed,